APP and Alzheimer disease: By using a model of AD-like β-amyloid (Aβ) pathology (double transgenic APP/PS1 mice), Lenka Maletínskáa’s team find that a PrRP analog (palm11-PrRP31) reduces the total amount of senile Aβ plaques in APP/PS1 mice.